Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.

Link J, Ramanujam R, Auer M, Ryner M, Hässler S, Bachelet D, Mbogning C, Warnke C, Buck D, Hyldgaard Jensen PE, Sievers C, Ingenhoven K, Fissolo N, Lindberg R, Grummel V, Donnellan N, Comabella M, Montalban X, Kieseier B, Soelberg Sørensen P, Hartung HP, Derfuss T, Lawton A, Sikkema D, Pallardy M, Hemmer B, Deisenhammer F, Broët P, Dönnes P, Davidson J, Fogdell-Hahn A, ABIRISK Consortium

Open source

DOI: 10.1371/journal.pone.0170395
Published: 2017
Container: PloS one
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0170395,
  title = {Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.},
  author = {Link J and Ramanujam R and Auer M and Ryner M and Hässler S and Bachelet D and Mbogning C and Warnke C and Buck D and Hyldgaard Jensen PE and Sievers C and Ingenhoven K and Fissolo N and Lindberg R and Grummel V and Donnellan N and Comabella M and Montalban X and Kieseier B and Soelberg Sørensen P and Hartung HP and Derfuss T and Lawton A and Sikkema D and Pallardy M and Hemmer B and Deisenhammer F and Broët P and Dönnes P and Davidson J and Fogdell-Hahn A and ABIRISK Consortium},
  year = {2017},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0170395},
  url = {https://doi.org/10.1371/journal.pone.0170395}
}

RIS

TY  - JOUR
TI  - Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.
AU  - Link J
AU  - Ramanujam R
AU  - Auer M
AU  - Ryner M
AU  - Hässler S
AU  - Bachelet D
AU  - Mbogning C
AU  - Warnke C
AU  - Buck D
AU  - Hyldgaard Jensen PE
AU  - Sievers C
AU  - Ingenhoven K
AU  - Fissolo N
AU  - Lindberg R
AU  - Grummel V
AU  - Donnellan N
AU  - Comabella M
AU  - Montalban X
AU  - Kieseier B
AU  - Soelberg Sørensen P
AU  - Hartung HP
AU  - Derfuss T
AU  - Lawton A
AU  - Sikkema D
AU  - Pallardy M
AU  - Hemmer B
AU  - Deisenhammer F
AU  - Broët P
AU  - Dönnes P
AU  - Davidson J
AU  - Fogdell-Hahn A
AU  - ABIRISK Consortium
PY  - 2017
JO  - PloS one
DO  - 10.1371/journal.pone.0170395
UR  - https://doi.org/10.1371/journal.pone.0170395
ER  -

APA

J, L., R, R., M, A., M, R., S, H., D, B., C, M., C, W., D, B., PE, H. J., C, S., K, I., N, F., R, L., V, G., N, D., M, C., X, M., B, K., P, S. S., HP, H., T, D., A, L., D, S., M, P., B, H., F, D., P, B., P, D., J, D., A, F., & Consortium, A. (2017). Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.. PloS one. https://doi.org/10.1371/journal.pone.0170395

Source records

pubmed · retrieved 2026-09-26T04:14:45.689Z